In conclusion, we found a significantly higher ABCB1 expression in esophageal adenocarcinomas than in squamous cell carcinomas, which might be causally related to a better treatment effectivity of paclitaxel in the latter. The gene discussed is ABCB1; the disease is esophageal adenocarcinoma.